Does the media favor ICLR or CRL?

In the previous week, Icon and Icon both had 4 articles in the media. Icon's average media sentiment score of 1.76 beat Charles River Laboratories International's score of 1.28 indicating that Icon is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Icon 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Charles River Laboratories International 4 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate IQV or ICLR?

IQVIA currently has a consensus target price of $243.63, indicating a potential downside of 7.05%. Icon has a consensus target price of $170.40, indicating a potential upside of 0.64%. Given Icon's higher probable upside, analysts clearly believe Icon is more favorable than IQVIA. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score IQVIA 0 Sell rating(s) 3 Hold rating(s) 13 Buy rating(s) 1 Strong Buy rating(s) 2.88 Icon 2 Sell rating(s) 7 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 2.41

Which has stronger valuation & earnings, IQV or ICLR?

IQVIA has higher revenue and earnings than Icon. IQVIA is trading at a lower price-to-earnings ratio than Icon, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio IQVIA $16.98B 2.54 $1.36B $8.06 32.52 Icon $8.29B 1.56 $229.34M $4.26 39.74

Is IQV or ICLR more profitable?

IQVIA has a net margin of 8.10% compared to Icon's net margin of 3.99%. IQVIA's return on equity of 30.25% beat Icon's return on equity. Company Net Margins Return on Equity Return on Assets IQVIA 8.10% 30.25% 6.54% Icon 3.99% 8.02% 4.56%

Does the media refer more to IQV or ICLR?

In the previous week, IQVIA had 18 more articles in the media than Icon. MarketBeat recorded 22 mentions for IQVIA and 4 mentions for Icon. Icon's average media sentiment score of 1.76 beat IQVIA's score of 1.01 indicating that Icon is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment IQVIA 14 Very Positive mention(s) 1 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Icon 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Does the media prefer A or ICLR?

In the previous week, Agilent Technologies had 15 more articles in the media than Icon. MarketBeat recorded 19 mentions for Agilent Technologies and 4 mentions for Icon. Icon's average media sentiment score of 1.76 beat Agilent Technologies' score of 0.68 indicating that Icon is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Agilent Technologies 10 Very Positive mention(s) 1 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Icon 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Which has preferable earnings & valuation, WAT or ICLR?

Waters has higher earnings, but lower revenue than Icon. Icon is trading at a lower price-to-earnings ratio than Waters, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Waters $4.64B 8.63 $642.63M $4.01 101.75 Icon $8.29B 1.56 $229.34M $4.26 39.74

Is WAT or ICLR more profitable?

Icon has a net margin of 3.99% compared to Waters' net margin of 3.58%. Waters' return on equity of 11.27% beat Icon's return on equity. Company Net Margins Return on Equity Return on Assets Waters 3.58% 11.27% 6.73% Icon 3.99% 8.02% 4.56%

Does the media prefer WAT or ICLR?

In the previous week, Waters had 18 more articles in the media than Icon. MarketBeat recorded 22 mentions for Waters and 4 mentions for Icon. Icon's average media sentiment score of 1.76 beat Waters' score of 0.55 indicating that Icon is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Waters 9 Very Positive mention(s) 3 Positive mention(s) 6 Neutral mention(s) 2 Negative mention(s) 1 Very Negative mention(s) Positive Icon 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Which has stronger valuation & earnings, ILMN or ICLR?

Illumina has higher earnings, but lower revenue than Icon. Illumina is trading at a lower price-to-earnings ratio than Icon, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Illumina $4.34B 7.18 $850M $5.36 38.52 Icon $8.29B 1.56 $229.34M $4.26 39.74

Is ILMN or ICLR more profitable?

Illumina has a net margin of 18.36% compared to Icon's net margin of 3.99%. Illumina's return on equity of 29.84% beat Icon's return on equity. Company Net Margins Return on Equity Return on Assets Illumina 18.36% 29.84% 12.17% Icon 3.99% 8.02% 4.56%

Does the media prefer ILMN or ICLR?

In the previous week, Illumina had 26 more articles in the media than Icon. MarketBeat recorded 30 mentions for Illumina and 4 mentions for Icon. Icon's average media sentiment score of 1.76 beat Illumina's score of 0.75 indicating that Icon is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Illumina 18 Very Positive mention(s) 3 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Icon 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Icon (ICLR) Competitors

$169.31 +3.62 (+2.18%)

Closing price 09/11/2026 04:00 PM Eastern

Extended Trading

$169.22 -0.09 (-0.05%)

As of 09/11/2026 07:30 PM Eastern

Compare

ICLR vs. CRL, IQV, A, WAT, and ILMN

Should you buy Icon stock or one of its competitors? Icon's main competitors and comparable companies include Charles River Laboratories International (CRL), IQVIA (IQV), Agilent Technologies (A), Waters (WAT), and Illumina (ILMN). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "life sciences tools & services" industry.

How does Icon compare to Charles River Laboratories International?

Icon (NASDAQ:ICLR) and Charles River Laboratories International (NYSE:CRL) are both large-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, profitability, media sentiment, risk, valuation, institutional ownership, analyst recommendations and earnings.

Icon has a beta of 1.2, indicating that its share price is 20% more volatile than the broader market. Comparatively, Charles River Laboratories International has a beta of 1.4, indicating that its share price is 40% more volatile than the broader market.

In the previous week, Icon and Icon both had 4 articles in the media. Icon's average media sentiment score of 1.76 beat Charles River Laboratories International's score of 1.28 indicating that Icon is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Icon	3 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Charles River Laboratories International	4 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

95.6% of Icon shares are held by institutional investors. Comparatively, 98.9% of Charles River Laboratories International shares are held by institutional investors. 44.0% of Icon shares are held by insiders. Comparatively, 1.3% of Charles River Laboratories International shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Icon has a net margin of 3.99% compared to Charles River Laboratories International's net margin of -5.96%. Charles River Laboratories International's return on equity of 15.75% beat Icon's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Icon	3.99%	8.02%	4.56%
Charles River Laboratories International	-5.96%	15.75%	6.51%

Icon presently has a consensus price target of $170.40, indicating a potential upside of 0.64%. Charles River Laboratories International has a consensus price target of $265.69, indicating a potential downside of 4.44%. Given Icon's higher probable upside, analysts plainly believe Icon is more favorable than Charles River Laboratories International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Icon	2 Sell rating(s)	7 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.41
Charles River Laboratories International	1 Sell rating(s)	3 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.67

Icon has higher revenue and earnings than Charles River Laboratories International. Charles River Laboratories International is trading at a lower price-to-earnings ratio than Icon, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Icon	$8.29B	1.56	$229.34M	$4.26	39.74
Charles River Laboratories International	$4.00B	3.32	-$144.34M	-$4.85	N/A

Summary

Icon beats Charles River Laboratories International on 9 of the 16 factors compared between the two stocks.

How does Icon compare to IQVIA?

IQVIA (NYSE:IQV) and Icon (NASDAQ:ICLR) are both large-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their media sentiment, valuation, analyst recommendations, dividends, risk, profitability, institutional ownership and earnings.

In the previous week, IQVIA had 18 more articles in the media than Icon. MarketBeat recorded 22 mentions for IQVIA and 4 mentions for Icon. Icon's average media sentiment score of 1.76 beat IQVIA's score of 1.01 indicating that Icon is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
IQVIA	14 Very Positive mention(s)	1 Positive mention(s)	7 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Icon	3 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

IQVIA has higher revenue and earnings than Icon. IQVIA is trading at a lower price-to-earnings ratio than Icon, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IQVIA	$16.98B	2.54	$1.36B	$8.06	32.52
Icon	$8.29B	1.56	$229.34M	$4.26	39.74

IQVIA has a beta of 1.18, suggesting that its share price is 18% more volatile than the broader market. Comparatively, Icon has a beta of 1.2, suggesting that its share price is 20% more volatile than the broader market.

IQVIA has a net margin of 8.10% compared to Icon's net margin of 3.99%. IQVIA's return on equity of 30.25% beat Icon's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
IQVIA	8.10%	30.25%	6.54%
Icon	3.99%	8.02%	4.56%

IQVIA currently has a consensus target price of $243.63, indicating a potential downside of 7.05%. Icon has a consensus target price of $170.40, indicating a potential upside of 0.64%. Given Icon's higher probable upside, analysts clearly believe Icon is more favorable than IQVIA.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
IQVIA	0 Sell rating(s)	3 Hold rating(s)	13 Buy rating(s)	1 Strong Buy rating(s)	2.88
Icon	2 Sell rating(s)	7 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.41

89.6% of IQVIA shares are owned by institutional investors. Comparatively, 95.6% of Icon shares are owned by institutional investors. 1.7% of IQVIA shares are owned by insiders. Comparatively, 44.0% of Icon shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Summary

IQVIA beats Icon on 10 of the 16 factors compared between the two stocks.

How does Icon compare to Agilent Technologies?

Agilent Technologies (NYSE:A) and Icon (NASDAQ:ICLR) are both large-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, risk, analyst recommendations, profitability, valuation, dividends, institutional ownership and earnings.

In the previous week, Agilent Technologies had 15 more articles in the media than Icon. MarketBeat recorded 19 mentions for Agilent Technologies and 4 mentions for Icon. Icon's average media sentiment score of 1.76 beat Agilent Technologies' score of 0.68 indicating that Icon is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Agilent Technologies	10 Very Positive mention(s)	1 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Icon	3 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Agilent Technologies has a beta of 1.24, meaning that its stock price is 24% more volatile than the broader market. Comparatively, Icon has a beta of 1.2, meaning that its stock price is 20% more volatile than the broader market.

Agilent Technologies presently has a consensus target price of $170.33, indicating a potential upside of 15.95%. Icon has a consensus target price of $170.40, indicating a potential upside of 0.64%. Given Agilent Technologies' stronger consensus rating and higher possible upside, analysts clearly believe Agilent Technologies is more favorable than Icon.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Agilent Technologies	0 Sell rating(s)	5 Hold rating(s)	14 Buy rating(s)	1 Strong Buy rating(s)	2.80
Icon	2 Sell rating(s)	7 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.41

Agilent Technologies has a net margin of 19.53% compared to Icon's net margin of 3.99%. Agilent Technologies' return on equity of 24.45% beat Icon's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Agilent Technologies	19.53%	24.45%	13.09%
Icon	3.99%	8.02%	4.56%

Agilent Technologies has higher earnings, but lower revenue than Icon. Agilent Technologies is trading at a lower price-to-earnings ratio than Icon, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Agilent Technologies	$7.37B	5.62	$1.30B	$5.08	28.92
Icon	$8.29B	1.56	$229.34M	$4.26	39.74

87.4% of Agilent Technologies shares are owned by institutional investors. Comparatively, 95.6% of Icon shares are owned by institutional investors. 0.2% of Agilent Technologies shares are owned by company insiders. Comparatively, 44.0% of Icon shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Summary

Agilent Technologies beats Icon on 11 of the 16 factors compared between the two stocks.

How does Icon compare to Waters?

Waters (NYSE:WAT) and Icon (NASDAQ:ICLR) are both large-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, risk, analyst recommendations, media sentiment, profitability, institutional ownership, earnings and valuation.

Waters has a beta of 1.19, meaning that its stock price is 19% more volatile than the broader market. Comparatively, Icon has a beta of 1.2, meaning that its stock price is 20% more volatile than the broader market.

In the previous week, Waters had 18 more articles in the media than Icon. MarketBeat recorded 22 mentions for Waters and 4 mentions for Icon. Icon's average media sentiment score of 1.76 beat Waters' score of 0.55 indicating that Icon is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Waters	9 Very Positive mention(s)	3 Positive mention(s)	6 Neutral mention(s)	2 Negative mention(s)	1 Very Negative mention(s)	Positive
Icon	3 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Icon has a net margin of 3.99% compared to Waters' net margin of 3.58%. Waters' return on equity of 11.27% beat Icon's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Waters	3.58%	11.27%	6.73%
Icon	3.99%	8.02%	4.56%

94.0% of Waters shares are owned by institutional investors. Comparatively, 95.6% of Icon shares are owned by institutional investors. 0.3% of Waters shares are owned by insiders. Comparatively, 44.0% of Icon shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Waters has higher earnings, but lower revenue than Icon. Icon is trading at a lower price-to-earnings ratio than Waters, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Waters	$4.64B	8.63	$642.63M	$4.01	101.75
Icon	$8.29B	1.56	$229.34M	$4.26	39.74

Waters currently has a consensus price target of $430.10, indicating a potential upside of 5.41%. Icon has a consensus price target of $170.40, indicating a potential upside of 0.64%. Given Waters' stronger consensus rating and higher probable upside, equities analysts plainly believe Waters is more favorable than Icon.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Waters	0 Sell rating(s)	6 Hold rating(s)	11 Buy rating(s)	3 Strong Buy rating(s)	2.85
Icon	2 Sell rating(s)	7 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.41

Summary

Waters beats Icon on 10 of the 17 factors compared between the two stocks.

How does Icon compare to Illumina?

Illumina (NASDAQ:ILMN) and Icon (NASDAQ:ICLR) are both large-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, valuation, risk, analyst recommendations, profitability, institutional ownership, dividends and earnings.

In the previous week, Illumina had 26 more articles in the media than Icon. MarketBeat recorded 30 mentions for Illumina and 4 mentions for Icon. Icon's average media sentiment score of 1.76 beat Illumina's score of 0.75 indicating that Icon is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Illumina	18 Very Positive mention(s)	3 Positive mention(s)	7 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Icon	3 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Illumina presently has a consensus target price of $199.13, indicating a potential downside of 3.55%. Icon has a consensus target price of $170.40, indicating a potential upside of 0.64%. Given Icon's higher possible upside, analysts plainly believe Icon is more favorable than Illumina.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Illumina	2 Sell rating(s)	6 Hold rating(s)	10 Buy rating(s)	0 Strong Buy rating(s)	2.44
Icon	2 Sell rating(s)	7 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.41

Illumina has a beta of 1.46, meaning that its share price is 46% more volatile than the broader market. Comparatively, Icon has a beta of 1.2, meaning that its share price is 20% more volatile than the broader market.

89.4% of Illumina shares are owned by institutional investors. Comparatively, 95.6% of Icon shares are owned by institutional investors. 2.9% of Illumina shares are owned by company insiders. Comparatively, 44.0% of Icon shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Illumina has higher earnings, but lower revenue than Icon. Illumina is trading at a lower price-to-earnings ratio than Icon, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Illumina	$4.34B	7.18	$850M	$5.36	38.52
Icon	$8.29B	1.56	$229.34M	$4.26	39.74

Illumina has a net margin of 18.36% compared to Icon's net margin of 3.99%. Illumina's return on equity of 29.84% beat Icon's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Illumina	18.36%	29.84%	12.17%
Icon	3.99%	8.02%	4.56%

Summary

Illumina beats Icon on 10 of the 17 factors compared between the two stocks.

Get Icon News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ICLR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ICLR vs. The Competition

Export

Metric	Icon	Life Sciences Tools & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$12.69B	$9.70B	$7.17B	$12.73B
Dividend Yield	N/A	1.47%	2.56%	11.15%
P/E Ratio	39.74	66.42	273.82	25.29
Price / Sales	1.56	287.66	656.53	99.10
Price / Cash	9.83	26.25	77.04	51.44
Price / Book	1.41	5.28	10.33	6.20
Net Income	$229.34M	$56.67B	$3.50B	$358.50M
7 Day Performance	2.71%	-2.10%	-3.33%	-2.35%
1 Month Performance	1.28%	-1.62%	-0.42%	-2.77%
1 Year Performance	-3.25%	25.10%	19.21%	7.64%

Icon Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ICLR Icon	2.499 of 5 stars	$169.31 +2.2%	$170.40 +0.6%	-3.3%	$12.69B	$8.29B	39.74	40,100	Positive News High Trading Volume
CRL Charles River Laboratories International	2.0272 of 5 stars	$289.02 -0.9%	$255.65 -11.5%	+74.1%	$13.92B	$4.02B	N/A	19,700	Positive News Analyst Forecast
IQV IQVIA	3.6939 of 5 stars	$261.29 -0.2%	$241.88 -7.4%	+37.6%	$43.08B	$16.31B	32.42	93,000	Positive News Analyst Upgrade
A Agilent Technologies	4.4604 of 5 stars	$153.79 0.0%	$170.33 +10.8%	+15.8%	$43.45B	$6.95B	30.27	18,100	Analyst Forecast
WAT Waters	3.3061 of 5 stars	$414.94 +0.1%	$424.35 +2.3%	+34.7%	$40.74B	$3.17B	103.48	7,900	Positive News Analyst Upgrade Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ICLR) was last updated on 9/12/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Icon (ICLR) Competitors

ICLR vs. CRL, IQV, A, WAT, and ILMN

How does Icon compare to Charles River Laboratories International?

Summary

How does Icon compare to IQVIA?

Summary

How does Icon compare to Agilent Technologies?

Summary

How does Icon compare to Waters?

Summary

How does Icon compare to Illumina?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ICLR vs. The Competition

Icon Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Icon (ICLR) Competitors

ICLR vs. CRL, IQV, A, WAT, and ILMN

How does Icon compare to Charles River Laboratories International?

Which has more volatility & risk, ICLR or CRL?

Does the media favor ICLR or CRL?

Do institutionals & insiders believe in ICLR or CRL?

Is ICLR or CRL more profitable?

Do analysts prefer ICLR or CRL?

Which has stronger earnings & valuation, ICLR or CRL?

Summary

How does Icon compare to IQVIA?

Does the media refer more to IQV or ICLR?

Which has stronger valuation & earnings, IQV or ICLR?

Which has more volatility and risk, IQV or ICLR?

Is IQV or ICLR more profitable?

Do analysts rate IQV or ICLR?

Do institutionals and insiders hold more shares of IQV or ICLR?

Summary

How does Icon compare to Agilent Technologies?

Does the media prefer A or ICLR?

Which has more risk and volatility, A or ICLR?

Do analysts rate A or ICLR?

Is A or ICLR more profitable?

Which has higher valuation and earnings, A or ICLR?

Do insiders & institutionals hold more shares of A or ICLR?

Summary

How does Icon compare to Waters?

Which has more volatility and risk, WAT or ICLR?

Does the media prefer WAT or ICLR?

Is WAT or ICLR more profitable?

Do insiders and institutionals believe in WAT or ICLR?

Which has preferable earnings & valuation, WAT or ICLR?

Do analysts rate WAT or ICLR?

Summary

How does Icon compare to Illumina?

Does the media prefer ILMN or ICLR?

Do analysts rate ILMN or ICLR?

Which has more volatility & risk, ILMN or ICLR?

Do institutionals & insiders believe in ILMN or ICLR?

Which has stronger valuation & earnings, ILMN or ICLR?

Is ILMN or ICLR more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ICLR vs. The Competition

Icon Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools